8-K Announcements
6Material company update
May 11, 2026·SEC
Material company update
Feb 23, 2026·SEC
Material company update
Jan 12, 2026·SEC
SI-BONE, Inc.(SIBN)Earnings, Financials & Key Ratios
SIBN•NASDAQ
Price updated Jun 19, 2026
AboutSI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.Show more
- Revenue$201M+20.2%
- EBITDA-$20M+36.5%
- Net Income-$19M+38.8%
- EPS (Diluted)-0.44+41.3%
- Gross Margin79.57%+0.7%
- EBITDA Margin-9.76%+47.1%
- Operating Margin-11.11%+47.3%
- Net Margin-9.41%+49.1%
- ROE-10.98%+40.3%
SIBN Key Insights
SI-BONE, Inc. (SIBN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 15.4%
- ✓Strong 5Y sales CAGR of 22.3%
✗Weaknesses
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SIBN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SIBN Price & Volume
SI-BONE, Inc. (SIBN) stock price & volume — 10-year historical chart
Loading chart...
SIBN Growth Metrics
SI-BONE, Inc. (SIBN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years17.18%
5 Years22.32%
3 Years23.6%
TTM16.77%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM37.1%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM39.39%
Return on Capital
10 Years-31.99%
5 Years-24.13%
3 Years-18.41%
Last Year-10.72%
SIBN Recent Earnings
SI-BONE, Inc. (SIBN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.10+41.2%
$0.17
Rev
$53M+2.8%
$51M
Q1 2026
Feb 23, 2026Metric
Actual
Est
EPS
$0.04+69.2%
$0.13
Rev
$56M+1.7%
$55M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.11+31.3%
$0.16
Rev
$49M-13.5%
$56M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$0.14+26.3%
$0.19
Rev
$49M+4.2%
$47M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.10vs $0.17+41.2% | $53Mvs $51M+2.8% |
| Q1 2026 | Feb 23, 2026 | $0.04vs $0.13+69.2% | $56Mvs $55M+1.7% |
| Q4 2025 | Nov 10, 2025 | $0.11vs $0.16+31.3% | $49Mvs $56M-13.5% |
| Q3 2025 | Aug 4, 2025 | $0.14vs $0.19+26.3% | $49Mvs $47M+4.2% |
Based on last 12 quarters of dataView full earnings history →
SIBN Peer Comparison
SI-BONE, Inc. (SIBN) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 XTNT | 61.8M | 0.44 | 14.69 | 14.21% | 1.5% | 3.68% | 0.56 | |
 ATEC | 1.33B | 8.81 | -9.18 | 24.95% | -21.07% | -443.09% | 17.21 | |
 NVAX | 1.5B | 9.13 | 3.59 | 64.69% | -14.73% | |||
 GMED | 10.69B | 79.23 | 20.21 | 16.65% | 18.92% | 13.04% | 0.03 | |
 OSIS | 3.67B | 222.78 | 25.58 | 11.33% | 8.42% | 16.74% | 0.72 | |
 OFIX | 381.98M | 9.45 | -4.14 | 2.85% | -7.27% | -13.44% | 0.51 | |
 IART | 1.37B | 17.58 | -2.61 | 1.53% | -30.15% | -47.65% | 1.95 | |
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 |
Compare SIBN vs Peers
SI-BONE, Inc. (SIBN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SIBN Income Statement
SI-BONE, Inc. (SIBN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 47.98M | 55.38M | 67.3M | 73.39M | 90.15M | 106.41M | 138.89M | 167.18M | 200.93M | 206.22M |
Revenue Growth % | 13.97% | 15.42% | 21.53% | 9.04% | 22.84% | 18.03% | 30.52% | 20.37% | 20.19% | 16.77% |
Cost of Goods Sold | 5.11M | 4.83M | 6.79M | 8.9M | 10.43M | 15.71M | 29.47M | 35.06M | 41.05M | 42.1M |
COGS % of Revenue | 10.65% | 8.73% | 10.09% | 12.13% | 11.57% | 14.76% | 21.22% | 20.97% | 20.43% | - |
Gross Profit | 42.87M▲ 0% | 50.55M▲ 17.9% | 60.51M▲ 19.7% | 64.48M▲ 6.6% | 79.72M▲ 23.6% | 90.7M▲ 13.8% | 109.42M▲ 20.6% | 132.12M▲ 20.7% | 159.88M▲ 21.0% | 164.13M▲ 0% |
Gross Margin % | 89.35% | 91.27% | 89.91% | 87.87% | 88.43% | 85.24% | 78.78% | 79.03% | 79.57% | 79.59% |
Gross Profit Growth % | 16.07% | 17.9% | 19.71% | 6.57% | 23.63% | 13.77% | 20.63% | 20.75% | 21.01% | - |
Operating Expenses | 60.22M | 62.51M | 96.51M | 103.05M | 131.39M | 150.31M | 156.35M | 167.37M | 182.21M | 184.07M |
OpEx % of Revenue | 125.5% | 112.88% | 143.41% | 140.42% | 145.75% | 141.26% | 112.58% | 100.11% | 90.68% | - |
Selling, General & Admin | 54.71M | 57.14M | 89.23M | 93.59M | 118.95M | 136.69M | 141.32M | 150.81M | 164.76M | 166.97M |
SG&A % of Revenue | 114.02% | 103.17% | 132.59% | 127.53% | 131.95% | 128.45% | 101.75% | 90.21% | 82% | - |
Research & Development | 5.51M | 5.38M | 7.28M | 9.46M | 12.44M | 13.63M | 15.03M | 16.56M | 17.45M | 17.11M |
R&D % of Revenue | 11.49% | 9.71% | 10.82% | 12.89% | 13.8% | 12.81% | 10.82% | 9.91% | 8.68% | - |
Other Operating Expenses | 340K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -17.35M▲ 0% | -11.96M▲ 31.0% | -36M▼ 200.9% | -38.57M▼ 7.1% | -51.67M▼ 34.0% | -59.61M▼ 15.4% | -46.93M▲ 21.3% | -35.25M▲ 24.9% | -22.33M▲ 36.6% | -19.94M▲ 0% |
Operating Margin % | -36.16% | -21.61% | -53.5% | -52.55% | -57.31% | -56.02% | -33.79% | -21.08% | -11.11% | -9.67% |
Operating Income Growth % | 1.22% | 31.04% | -200.9% | -7.12% | -33.97% | -15.36% | 21.27% | 24.89% | 36.65% | - |
EBITDA | -16.34M | -11.24M | -35.23M | -37.44M | -49.58M | -56.16M | -41.5M | -30.87M | -19.61M | -11.79M |
EBITDA Margin % | -34.05% | -20.3% | -52.35% | -51.01% | -55% | -52.77% | -29.88% | -18.46% | -9.76% | -5.72% |
EBITDA Growth % | 1.15% | 31.18% | -213.34% | -6.27% | -32.45% | -13.26% | 26.09% | 25.62% | 36.47% | 54.86% |
D&A (Non-Cash Add-back) | 1.01M | 722K | 774K | 1.13M | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M | 8.15M |
EBIT | -16.84M | -12.35M | -33.45M | -37.6M | -53.05M | -58.44M | -39.87M | -27.47M | -13.63M | -15.49M |
Net Interest Income | -6.03M | -4.34M | -2.4M | -5M | -5.18M | -1.51M | 3.45M | 4.41M | 790K | 3.27M |
Interest Income | 175K | 769K | 2.55M | 1.1M | 186K | 1.3M | 6.92M | 7.85M | 6.07M | 5.83M |
Interest Expense | 6.2M | 5.11M | 4.95M | 6.1M | 5.37M | 2.82M | 3.46M | 3.44M | 5.28M | 2.56M |
Other Income/Expense | -5.69M | -5.49M | -2.4M | -5.13M | -4.9M | -1.65M | 3.6M | 4.33M | 3.42M | 3.24M |
Pretax Income | -23.04M▲ 0% | -17.45M▲ 24.2% | -38.4M▼ 120.0% | -43.7M▼ 13.8% | -56.57M▼ 29.5% | -61.26M▼ 8.3% | -43.34M▲ 29.3% | -30.91M▲ 28.7% | -18.91M▲ 38.8% | -16.7M▲ 0% |
Pretax Margin % | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% | -8.1% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -23.04M▲ 0% | -17.45M▲ 24.2% | -38.4M▼ 120.0% | -43.7M▼ 13.8% | -56.57M▼ 29.5% | -61.26M▼ 8.3% | -43.34M▲ 29.3% | -30.91M▲ 28.7% | -18.91M▲ 38.8% | -16.7M▲ 0% |
Net Margin % | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% | -8.1% |
Net Income Growth % | -11.9% | 24.25% | -120.04% | -13.79% | -29.46% | -8.28% | 29.25% | 28.67% | 38.83% | 37.1% |
Net Income (Continuing) | -23.04M | -17.45M | -38.4M | -43.7M | -56.57M | -61.26M | -43.34M | -30.91M | -18.91M | -16.7M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.66▲ 0% | -1.10▲ 33.7% | -1.72▼ 56.4% | -1.50▲ 12.8% | -1.71▼ 14.0% | -1.79▼ 4.7% | -1.13▲ 36.9% | -0.75▲ 33.6% | -0.44▲ 41.3% | -0.38▲ 0% |
EPS Growth % | -24.81% | 33.73% | -56.36% | 12.79% | -14% | -4.68% | 36.87% | 33.63% | 41.33% | 39.39% |
EPS (Basic) | -1.66 | -1.10 | -1.72 | -1.50 | -1.71 | -1.79 | -1.13 | -0.75 | -0.44 | - |
Diluted Shares Outstanding | 13.87M | 15.9M | 24.71M | 29.06M | 33.15M | 34.2M | 38.43M | 41.47M | 43.51M | 43.96M |
Basic Shares Outstanding | 13.87M | 15.9M | 24.71M | 29.06M | 33.15M | 34.2M | 38.43M | 41.47M | 43.51M | 43.96M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
SIBN Balance Sheet
SI-BONE, Inc. (SIBN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 33.63M | 136.04M | 111.46M | 218.24M | 175.87M | 137.61M | 211.39M | 207.78M | 216.12M | 214.72M |
Cash & Short-Term Investments | 22.41M | 122.22M | 91.78M | 196.43M | 146.98M | 97.29M | 166.02M | 150.04M | 147.82M | 144.68M |
Cash Only | 22.41M | 25.12M | 10.44M | 53.58M | 63.42M | 20.72M | 33.27M | 34.95M | 42.24M | 33.53M |
Short-Term Investments | 0 | 97.1M | 81.34M | 142.85M | 83.56M | 76.57M | 132.75M | 115.09M | 105.58M | 111.15M |
Accounts Receivable | 7.42M | 8.49M | 11.72M | 13.61M | 14.25M | 20.67M | 21.95M | 27.46M | 29.91M | 30.96M |
Days Sales Outstanding | 56.41 | 55.93 | 63.56 | 67.7 | 57.68 | 70.92 | 57.69 | 59.95 | 54.34 | 49.46 |
Inventory | 2.55M | 3.34M | 5.45M | 5.63M | 11.5M | 17.28M | 20.25M | 27.07M | 33.9M | 35.53M |
Days Inventory Outstanding | 182.29 | 252.47 | 293.08 | 230.96 | 402.45 | 401.65 | 250.83 | 281.88 | 301.42 | 302.18 |
Other Current Assets | 0 | 1.99M | 0 | 0 | 0 | 2.37M | 3.17M | 3.2M | 4.48M | 3.54M |
Total Non-Current Assets | 2.21M | 2.48M | 5.55M | 4.9M | 14.64M | 19.94M | 19.03M | 22.66M | 22.44M | 28M |
Property, Plant & Equipment | 1.9M | 2.15M | 3.95M | 4.53M | 14.24M | 19.57M | 18.71M | 22.36M | 22.39M | 27.78M |
Fixed Asset Turnover | 25.31x | 25.71x | 17.02x | 16.21x | 6.33x | 5.44x | 7.42x | 7.48x | 8.98x | 8.55x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 7.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 269K | 325K | 315K | 374K | 400K | 375K | 325K | 300K | 55K | 217K |
Total Assets | 35.83M▲ 0% | 138.52M▲ 286.6% | 117.01M▼ 15.5% | 223.14M▲ 90.7% | 190.51M▼ 14.6% | 157.55M▼ 17.3% | 230.43M▲ 46.3% | 230.44M▲ 0.0% | 238.56M▲ 3.5% | 242.72M▲ 0% |
Asset Turnover | 1.34x | 0.40x | 0.58x | 0.33x | 0.47x | 0.68x | 0.60x | 0.73x | 0.84x | 0.87x |
Asset Growth % | -9.13% | 286.56% | -15.53% | 90.7% | -14.63% | -17.3% | 46.25% | 0.01% | 3.52% | 16.68% |
Total Current Liabilities | 7.54M | 9.01M | 18.77M | 13.47M | 16.89M | 21.18M | 23.46M | 27.13M | 25.28M | 21.49M |
Accounts Payable | 1.81M | 2.15M | 2.81M | 3.27M | 3.2M | 6.28M | 4.59M | 6.49M | 4.63M | 6.76M |
Days Payables Outstanding | 129.52 | 162.07 | 151.11 | 134.12 | 111.94 | 145.93 | 56.83 | 67.55 | 41.18 | 57.68 |
Short-Term Debt | 0 | 0 | 4.36M | 0 | 0 | 0 | 0 | 0 | 944K | 658K |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1.53M | 5.56M | 8.01M | 9.69M | 11.36M | 12.34M | 15.16M | 14.85M | 19.7M | 14.07M |
Current Ratio | 4.46x | 15.11x | 5.94x | 16.20x | 10.41x | 6.50x | 9.01x | 7.66x | 8.55x | 9.99x |
Quick Ratio | 4.12x | 14.73x | 5.65x | 15.78x | 9.73x | 5.68x | 8.15x | 6.66x | 7.21x | 8.34x |
Cash Conversion Cycle | 109.18 | 146.33 | 205.53 | 164.54 | 348.19 | 326.64 | 251.69 | 274.28 | 314.58 | 293.96 |
Total Non-Current Liabilities | 157.67M | 39.32M | 35.23M | 40.31M | 39.2M | 38.07M | 37.59M | 36.34M | 35.74M | 42.29M |
Long-Term Debt | 38.7M | 38.96M | 34.87M | 39.45M | 34.97M | 35.17M | 36.06M | 35.45M | 175K | 6.69M |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 4.17M | 2.87M | 1.51M | 879K | 0 | 483K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 118.97M | 360K | 362K | 854K | 57K | 30K | 18K | 10K | 35.57M | 35.6M |
Total Liabilities | 165.21M | 48.33M | 54M | 53.78M | 56.09M | 59.25M | 61.05M | 63.47M | 61.02M | 63.78M |
Total Debt | 38.7M | 38.96M | 39.22M | 39.45M | 40.48M | 39.43M | 38.99M | 37.48M | 1.12M | 7.35M |
Net Debt | 16.3M | 13.84M | 28.79M | -14.13M | -22.94M | 18.71M | 5.72M | 2.54M | -41.12M | -26.19M |
Debt / Equity | - | 0.43x | 0.62x | 0.23x | 0.30x | 0.40x | 0.23x | 0.22x | 0.01x | 0.04x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.62x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 2.22x |
Interest Coverage | -2.71x | -2.42x | -6.76x | -6.16x | -9.89x | -20.73x | -11.52x | -7.99x | -2.58x | -6.06x |
Total Equity | -129.38M▲ 0% | 90.19M▲ 169.7% | 63.01M▼ 30.1% | 169.36M▲ 168.8% | 134.42M▼ 20.6% | 98.3M▼ 26.9% | 169.38M▲ 72.3% | 166.96M▼ 1.4% | 177.53M▲ 6.3% | 178.94M▲ 0% |
Equity Growth % | -18.99% | 169.71% | -30.14% | 168.8% | -20.63% | -26.87% | 72.3% | -1.42% | 6.33% | 21.05% |
Book Value per Share | -9.33 | 5.67 | 2.55 | 5.83 | 4.06 | 2.87 | 4.41 | 4.03 | 4.08 | 4.07 |
Total Shareholders' Equity | -129.38M | 90.19M | 63.01M | 169.36M | 134.42M | 98.3M | 169.38M | 166.96M | 177.53M | 178.94M |
Common Stock | 1K | 3K | 3K | 3K | 3K | 3K | 4K | 4K | 626.97M | 4K |
Retained Earnings | -139.72M | -157.18M | -195.58M | -239.28M | -295.85M | -357.11M | -400.44M | -431.35M | -450.26M | -454.59M |
Treasury Stock | -9.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 402K | 439K | 464K | 524K | 352K | 232K | 335K | 244K | 816K | 501K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIBN Cash Flow Statement
SI-BONE, Inc. (SIBN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -17.53M | -14.52M | -31.63M | -30.66M | -39.53M | -41.66M | -18.71M | -12.43M | -675K | 1.87M |
Operating CF Margin % | -36.53% | -26.22% | -46.99% | -41.78% | -43.85% | -39.15% | -13.47% | -7.43% | -0.34% | - |
Operating CF Growth % | -4.64% | 17.18% | -117.83% | 3.05% | -28.93% | -5.37% | 55.08% | 33.6% | 94.57% | 874.5% |
Net Income | -23.04M | -17.45M | -38.4M | -43.7M | -56.57M | -61.26M | -43.34M | -30.91M | -18.9M | -16.7M |
Depreciation & Amortization | 1.01M | 722K | 774K | 1.13M | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M | 8.15M |
Stock-Based Compensation | 1.44M | 2.31M | 7.46M | 11.93M | 16.87M | 23.06M | 24.06M | 25.87M | 25.52M | 18.86M |
Deferred Taxes | 1.95M | 664K | 0 | 0 | 3.56M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 722K | 259K | -983K | 2.5M | 288K | 730K | -29K | -1.64M | 4.31M | 5.63M |
Working Capital Changes | 382K | -1.02M | -479K | -2.53M | -5.76M | -7.64M | -4.83M | -10.12M | -14.32M | -14.07M |
Change in Receivables | -1.31M | -1.02M | -3.24M | -2.19M | -569K | -6.48M | -2.12M | -5.84M | -3.03M | -4.72M |
Change in Inventory | -980K | -759K | -2.1M | -274K | -5.78M | -5.71M | -4.72M | -8.05M | -8.68M | -6.95M |
Change in Payables | 811K | 251K | 383K | 835K | -532K | 2.53M | -1.12M | 1.86M | -1.76M | -617K |
Cash from Investing | -478K | -97.83M | 13.49M | -62.92M | 51.58M | -2.81M | -59.8M | 12.62M | 4.16M | -12.7M |
Capital Expenditures | -478K | -942K | -2.44M | -2.56M | -6.39M | -9.51M | -7.8M | -10.5M | -8.41M | -7.42M |
CapEx % of Revenue | 1% | 1.7% | 3.63% | 3.49% | 7.09% | 8.93% | 5.62% | 6.28% | 4.19% | 3.6% |
Acquisitions | 0 | 0 | 0 | 0 | -57.97M | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | -96.88M | 0 | 0 | 57.97M | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 12.86M | 115.15M | 3.49M | 136.4M | -1.71M | 2.2M | 90.93M | 1.96M | 3.38M | 3.31M |
Debt Issued (Net) | 13.69M | 0 | 0 | -750K | -6.62M | 0 | 725K | 0 | 0 | 0 |
Equity Issued (Net) | 5.43M | 115.51M | 3.53M | 137.99M | 4.91M | 2.2M | 83.67M | 0 | 3.38M | 3.3M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -6.25M | -356K | -38K | -843K | 0 | 0 | 6.54M | 1.96M | 0 | 11K |
Net Change in Cash | -5.49M▲ 0% | 2.71M▲ 149.4% | -14.69M▼ 641.5% | 43.15M▲ 393.8% | 9.84M▼ 77.2% | -42.7M▼ 534.1% | 12.55M▲ 129.4% | 1.68M▼ 86.6% | 7.29M▲ 334.8% | -7.65M▲ 0% |
Free Cash Flow | -18.01M▲ 0% | -15.46M▲ 14.1% | -34.07M▼ 120.4% | -33.22M▲ 2.5% | -45.92M▼ 38.2% | -51.16M▼ 11.4% | -26.51M▲ 48.2% | -22.92M▲ 13.5% | -9.09M▲ 60.3% | -5.54M▲ 0% |
FCF Margin % | -37.53% | -27.92% | -50.63% | -45.27% | -50.94% | -48.08% | -19.09% | -13.71% | -4.52% | -2.69% |
FCF Growth % | -4.73% | 14.14% | -120.37% | 2.49% | -38.22% | -11.41% | 48.18% | 13.54% | 60.35% | 72.62% |
FCF per Share | -1.30 | -0.97 | -1.38 | -1.14 | -1.39 | -1.50 | -0.69 | -0.55 | -0.21 | -0.13 |
FCF Conversion (FCF/Net Income) | 0.76x | 0.83x | 0.82x | 0.70x | 0.70x | 0.68x | 0.43x | 0.40x | 0.04x | 0.33x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.35M | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIBN Key Ratios
SI-BONE, Inc. (SIBN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -19.35% | -50.13% | -37.61% | -37.24% | -52.64% | -32.38% | -18.38% | -10.98% | -9.56% |
Return on Invested Capital (ROIC) | - | - | -27.58% | -23.42% | -29.06% | -39.13% | -24.1% | -15.34% | -10.95% | -9.28% |
Gross Margin | 89.35% | 91.27% | 89.91% | 87.87% | 88.43% | 85.24% | 78.78% | 79.03% | 79.57% | 79.59% |
Net Margin | -48.01% | -31.51% | -57.06% | -59.54% | -62.75% | -57.57% | -31.2% | -18.49% | -9.41% | -8.1% |
Debt / Equity | - | 0.43x | 0.62x | 0.23x | 0.30x | 0.40x | 0.23x | 0.22x | 0.01x | 0.04x |
Interest Coverage | -2.71x | -2.42x | -6.76x | -6.16x | -9.89x | -20.73x | -11.52x | -7.99x | -2.58x | -6.06x |
FCF Conversion | 0.76x | 0.83x | 0.82x | 0.70x | 0.70x | 0.68x | 0.43x | 0.40x | 0.04x | 0.33x |
Revenue Growth | 13.97% | 15.42% | 21.53% | 9.04% | 22.84% | 18.03% | 30.52% | 20.37% | 20.19% | 16.77% |
Related:SIBN Dividend History·SIBN Revenue History·SIBN Price History·SIBN P/E History·SIBN Financial Ratios·SIBN Institutional Holders
SIBN SEC Filings & Documents
SI-BONE, Inc. (SIBN) SEC filings — annual & quarterly reports (10-K, 10-Q)
SIBN Frequently Asked Questions
SI-BONE, Inc. (SIBN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SI-BONE, Inc. (SIBN) reported $206.2M in revenue for fiscal year 2025. This represents a 321% increase from $49.0M in 2013.
SI-BONE, Inc. (SIBN) grew revenue by 20.2% over the past year. This is strong growth.
SI-BONE, Inc. (SIBN) reported a net loss of $16.7M for fiscal year 2025.
Dividend & Returns
SI-BONE, Inc. (SIBN) has a return on equity (ROE) of -11.0%. Negative ROE indicates the company is unprofitable.
SI-BONE, Inc. (SIBN) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.